Eisai Announces US Availability of DAYVIGO® (lemborexant) CIV, a New Treatment Option for Adults With Insomnia - PRNewswire

Submitted by Anonymous (not verified) on Mon, 06/01/2020 - 12:05

Eisai Announces US Availability of DAYVIGO® (lemborexant) CIV, a New Treatment Option for Adults With Insomnia  PRNewswire